Abstract
The UK has a strong tradition of providing excellent, evidence-based asthma guidelines,1 and a totally inglorious one of having some of the worst asthma outcomes in the world.2 Addressing these poor outcomes must top the agenda for those taking forward the forthcoming UK National Institute for Health and Care Excellence (NICE), British Thoracic Society (BTS), and Scottish Intercollegiate Guidelines Network (SIGN) guidelines on the diagnosis, monitoring, and management of chronic asthma.3 The challenge for the group developing these guidelines is to think radically, and produce a document that drives real change in outcomes, including mandating sanctions for non-compliance with new clinical practice recommendations.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
